A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia
- 12 April 2013
- journal article
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 16 (6) , 720-735
Abstract
(2013). A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. Journal of Medical Economics: Vol. 16, No. 6, pp. 720-735.Keywords
This publication has 27 references indexed in Scilit:
- Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databasesBMC Health Services Research, 2013
- Costs Associated with Febrile Neutropenia in the USPharmacoEconomics, 2012
- Trends in Neutropenia-Related Inpatient EventsJournal of Oncology Practice, 2012
- Costs of Home Versus Inpatient Treatment for Fever and Neutropenia: Analysis of a Multicenter Randomized TrialJournal of Clinical Oncology, 2011
- Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective studyExperimental and Therapeutic Medicine, 2011
- Febrile neutropenia: A critical review of the initial managementCritical Reviews in Oncology/Hematology, 2011
- 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursEuropean Journal of Cancer, 2011
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Population-based Assessment of Hospitalizations for Neutropenia from Chemotherapy in Older Adults with Non-Hodgkin’s Lymphoma (United States)Cancer Causes & Control, 2006
- Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapyCancer, 2005